title: Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists.
abstract: OBJECTIVE
  To investigate the attitude of Greek obstetrician-gynaecologists towards prescription of hormone therapy to postmenopausal breast cancer survivors.
  
  
  METHODS
  An anonymous questionnaire was sent to members of the Hellenic Society of Obstetrics and Gynaecology with a hypothetical case and a series of relevant questions.
  
  
  RESULTS
  Three hundred valid answers were received. Hormone therapy would be prescribed to a breast cancer survivor by only 8%; 80% of these would prefer tibolone. In contrast, 92% would not prescribe hormone therapy; 97% would do so due to the risk of disease recurrence; 70% would not prescribe any alternative therapy, 21% would prescribe CNS-active compounds and 7% SERMs.
  
  
  CONCLUSIONS
  The vast majority of Greek obstetrician-gynaecologists would not prescribe hormone therapy for menopausal symptoms in breast cancer survivors due to the theoretical risk of disease recurrence. Among those who would not prescribe hormone therapy, 21% would opt to CNS-active compounds.
authors.affiliation: Department of Obstetrics and Gynaecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, Greece. vavilis@auth.gr
authors.forename: D
authors.initials: D
authors.lastname: Vavilis
authors.forename: M
authors.initials: M
authors.lastname: Zafrakas
authors.forename: D G
authors.initials: DG
authors.lastname: Goulis
authors.forename: K
authors.initials: K
authors.lastname: Pantazis
authors.forename: T
authors.initials: T
authors.lastname: Agorastos
authors.forename: J N
authors.initials: JN
authors.lastname: Bontis